Philip M Laws (Philip Laws)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Clinical Practice

Cross Sectional

Top Venues

The British journal of dermatology

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Michael R Ardern-Jones, Sara J Brown, Carsten Flohr, Parwez N Hossain, Alan D Irvine, Graham A Johnston, Mark Lane, Sinéad M Langan, Philip M Laws, Daniel O'Driscoll, Donal O'Kane, Alice Payne, Gabriela Petrof, Andrew E Pink, Saaeha Rauz, Scott Robbie, Sri K Gore, Mili Shah, Richard T Woolf, Chenxi Wang, Stoyana Tumbeva, M Firouz Mohd Mustapa
An expert consensus on managing dupilumab-related ocular surface disorders in people with atopic dermatitis 2024. The British journal of dermatology (2024)
Fiona Campbell, Philip M Laws
Managing risk of liver fibrosis in patients with psoriasis being considered for methotrexate. The British journal of dermatology 191 (2) (2024)
Fiona Campbell, Philip M Laws
Managing risk of liver fibrosis in psoriatic patients being considered for methotrexate. The British journal of dermatology (2024)
Stephanie Rose Harrison, Fiona Campbell, Hannah Bennett, Gabriele de Marco, Philip S Helliwell, Rebecca Golenya, Dennis G McGonagle, Cleone Riad, Pavan Sambi, Kave Shams, David Wright, Helena Marzo-Ortega, Philip M Laws
High prevalence of undiagnosed and undertreated psoriasis in a UK urban population: results from the observational COPPACA study. The British journal of dermatology (2024)
Timothy Raine, Maria Angeliki Gkini, Peter M Irving, Arvind Kaul, Eleanor Korendowych, Philip M Laws, Amy Charlotte Foulkes
Maintaining Clinical Freedom Whilst Achieving Value in Biologics Prescribing: An Integrated Cross-Specialty Consensus of UK Dermatologists, Rheumatologists and Gastroenterologists. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 35 (2) (2021)